International Conference on Hybrid Imaging (IPET 2024) - Programme - Day 2

IAEA Headquarters, Vienna, Austria

Note: This page will be updated as more information about the sessions is added.

09:00 – 10:00 | Session 5: Prostate Cancer Theranostics

10:00 – 10:30 | Coffee break and Exhibition Visit/Presentation

10:30 – 11:30 | Session 5: Prostate Cancer Theranostics (continued)

11:30 – 13:00 | Session 6: Neuroendocrine Tumours

13:00 – 14:30 | Working lunch: Collaborative Impact: The Role of Professional Organizations in Advancing Nuclear Medicine and Diagnostic Imaging 
(Professional Organisations: EANM, ESR, ICPO, ISR ISORBE, RSNA, SNMMI, WARMTH, WFNMB)

14:30 – 16:15 | Session 7: Breast Cancer

16:15 – 16:40 | Coffee break and Exhibition Visit/Presentation

16:40 – 18:00 | Session 8: Poster Review 2/4

17:00 – 17:30 | Coordinated Research Projects (POCA/PROCA) Session 2

16:40 – 18:00 | Information: A key resource to achieve peaceful uses of nuclear technologies

09:00 – 10:00

Chairperson: Irene Virgolini, World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)
Co-Chair: Homer Macapinlac, USA

09:00 – 09:20 | Role of Multiparametric MRI in Prostate Cancer
Tharakeswara Kumar Bathala, University of Texas MD Anderson Cancer Center

09:20 – 09:40 | Role of PSMA PET/CT and PET/MRI in Prostate Cancer
Devaki Shilpa Surasi, University of Texas MD Anderson Cancer Center

09:40 – 10:00 | Role of PSMA PET/CT and PET/MRI in Prostate Cancer
Karen Elizabeth Hoffman, University of Texas MD Anderson Cancer Center

10:30 – 11:30

Chairperson: Kgomotso Mokoala, World Federation of Nuclear Medicine and Biology (WFNMB)
Co-Chair: Homer Macapinlac, USA

10:30 – 10:50 | Conventional Therapies in Prostate Cancer: Medical Oncologist Perspective
Amado Zurita-Saavedra, University of Texas MD Anderson Cancer Center

10:50 – 11:10 | Role and Advances in Labelled PSMA Therapies
Stefano Fanti, Italy

11:10 – 11:30 | Interactive Case Discussion / Tumour Board
Panellists: Tharakeswara Kumar Bathala, Devaki Shilpa Surasi, Karen Elizabeth Hoffman, Amado Zurita-Saavedra, Stefano Fanti, Omar Alonso, Fuad Novruzov and Akram Al-Ibraheem, Mike Sathekge

11:30 – 13:00

IAEA Coordinator: Francesco Giammarile, Scientific Secretary, Nuclear Medicine Physician, IAEA
Chairperson: Sona Balogova, European Association of Nuclear Medicine (EANM)

11:30 – 11:45 | Radiopharmaceutical Trends
John Prior, Switzerland

11:45 – 12:05 | Where we are and Where we are going: The Future of Theranostics
Andrei Iagaru, Standford Health Care (SHC)

12:05 – 12:45 | Interactive Case Discussion 
Irene Virgolini,  Masha Maharaj, Kalevi Kairemo, Mariela Agolti, Partha Choudhury, Akram Al-Ibraheem, World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)

12:45 – 13:00 | Where we are and Where we are going: The Future of Theranostics
Panellists: John Prior, Andrei Iagaru, Francesco Giammarile,  Irene Virgolini

14:30 – 16:15

IAEA Coordinator: Miriam Mikhail-Lette, Radiologist, IAEA
Chairperson: Jolanta Kunikowska, Poland

14:30 – 14:45 | Screening: Role of Ultrasound and Mammography
Boris Brkljacic, International Society of Radiology (ISR)

14:45 – 15:00 | Breast MRI
Pascal Baltzer, International Society of Radiology (ISR)

15:00 – 15:15 | Interventional Breast Imaging
Boris Brkljacic, International Society of Radiology (ISR)

15:15 – 15:30 | Role of PET
Rakesh Kumar, India

15:30 – 15:45 | Molecular Breast Imaging: The Emerging Role of CZT 
Michael O'Connor, USA

15:45 – 16:15 | Interactive Case Discussion
Boris Brkljacic and Pascal Baltzer, International Society of Radiology (ISR)

16:40 – 18:00

Chairperson: Olivier Pellet, Radiologist, IAEA

Reviewers: Mohamad Haidar, Juliano Cerci, Francisca Redondo, Akram Al-Ibraheem, Jolanta Kunikowska, Pavlo Korol, Paola Hilda Corona

17:00 – 17:30

Note: Closed sessions reserved for POCA and PROCA investigators.

16:40 – 18:00

Dibuleng Mohlakwana, Head of Nuclear Information Section, IAEA